Le Lézard
Classified in: Health
Subjects: MAV, SCZ, FVT, CFG

/R E P E A T -- Notice to the media - Minister of Health to make announcement on dementia/


TORONTO, June 14, 2019 /CNW/ - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will announce new Government of Canada actions to improve the lives of Canadians living with dementia, as well as that of their families and caregivers.

The Minister will be available to media following the announcement.

Date
Monday, June 17, 2019

Time
9:30 A.M. (EDT)

Location
Villa Colombo Toronto
40 Playfair Avenue
Toronto, Ontario M6B 2P9

Outdoor gardens
Rain location: Sala Caboto

 

 

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 16:35
AVROBIO, Inc. , a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today shared an update on its response to the COVID-19 pandemic and a current assessment of the impact on AVROBIO's...

at 16:30
Like so many others, I have been reflecting on what we have lived through for the past few weeks. We have been faced with dozens of challenges and decisions that we haven't had to deal with before in our lives or careers. And these are exactly the...

at 16:30
NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results for the...

at 16:25
Air Canada said today that due to the unprecedented impact of Covid-19 upon its business, the airline will reduce capacity for the Second Quarter of 2020 by 85%-90% compared to last year's Q2 and will place 15,200 members of its unionized workforce...

at 16:20
Maya Gold & Silver Inc. ("Maya" or the "Corporation") has postponed filing its annual financial statements, management's discussion and analysis and annual information form for the year ended December 31, 2019 (collectively the "2019 annual...

at 16:15
INVO Bioscience, Inc. , a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced financial results...



News published on 17 june 2019 at 06:00 and distributed by: